BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16314688)

  • 1. Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
    Omiya Y; Suzuki Y; Yuzurihara M; Murata M; Aburada M; Kase Y; Takeda S
    J Pharmacol Sci; 2005 Dec; 99(4):373-80. PubMed ID: 16314688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
    Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
    Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of alpha2-adrenoceptors in enhancement of antinociceptive effect in diabetic mice.
    Omiya Y; Yuzurihara M; Suzuki Y; Kase Y; Kono T
    Eur J Pharmacol; 2008 Sep; 592(1-3):62-6. PubMed ID: 18625215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of Gosha-jinki-gan, a Kampo medicine, in streptozotocin-induced diabetic mice.
    Suzuki Y; Goto K; Ishige A; Komatsu Y; Kamei J
    Jpn J Pharmacol; 1999 Feb; 79(2):169-75. PubMed ID: 10202852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effect of paeoniflorin via spinal α₂-adrenoceptor activation in diabetic mice.
    Lee KK; Omiya Y; Yuzurihara M; Kase Y; Kobayashi H
    Eur J Pain; 2011 Nov; 15(10):1035-9. PubMed ID: 21596599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotropin induces antinociceptive effect by enhancing descending pain inhibitory systems involving 5-HT3 and noradrenergic alpha2 receptors in spinal dorsal horn.
    Kawamura M; Ohara H; Go K; Koga Y; Ienaga K
    Life Sci; 1998; 62(24):2181-90. PubMed ID: 9627076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of analgesic action of neurotropin on chronic pain in adjuvant-induced arthritic rat: roles of descending noradrenergic and serotonergic systems.
    Miura T; Okazaki R; Yoshida H; Namba H; Okai H; Kawamura M
    J Pharmacol Sci; 2005 Mar; 97(3):429-36. PubMed ID: 15764839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive mechanisms of orally administered decursinol in the mouse.
    Choi SS; Han KJ; Lee JK; Lee HK; Han EJ; Kim DH; Suh HW
    Life Sci; 2003 Jun; 73(4):471-85. PubMed ID: 12759141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice.
    Ochi T; Ohkubo Y; Mutoh S
    Neurosci Lett; 2002 Apr; 322(2):95-8. PubMed ID: 11958852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.